Annual report pursuant to Section 13 and 15(d)

STOCK COMPENSATION PLANS (Details)

v3.6.0.2
STOCK COMPENSATION PLANS (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
STOCK COMPENSATION PLANS [Abstract]      
Total stock-based compensation expense $ 258.0 $ 236.0 $ 209.0
Total income tax benefit recognized in consolidated statements of income for share-based compensation arrangements 71.0 $ 65.0 $ 57.0
Total unrecognized compensation cost related to nonvested share-based compensation arrangements granted $ 267.0    
Weighted-average period over which the total unrecognized compensation cost is expected to be recognized (in years) 1 year 5 months 21 days    
Weighted-average assumptions used in the Black Scholes Merton option pricing model      
Fair value of options at grant date (in dollars per share) $ 4.17 $ 4.38 $ 3.91
Dividend yield (as a percent) 3.20% 3.10% 2.70%
Expected volatility (as a percent) 16.00% 16.00% 16.00%
Risk-free interest rate (as a percent) 1.50% 1.80% 1.60%
Expected term of the option (in years) 6 years 6 years 5 years
Share-based compensation disclosure      
Granted (in shares) 9,000,000    
Exercised (in shares) (50,000,000) (44,000,000) (58,000,000)
Forfeited/expired (in shares) (5,000,000)    
Outstanding on December 31 220,000,000 266,000,000  
Expected to vest 219,000,000    
Granted, Weighted-Average Exercise Price (in dollars per share) $ 43.52    
Exercised, Weighted-Average Exercise Price (in dollars per share) 28.68    
Forfeited/expired, Weighted-Average Exercise Price (in dollars per share) 37.18    
Outstanding on December 31, Weighted-Average Exercise Price (in dollars per share) 33.70 $ 32.51  
Expected to vest, Weighted-Average Exercise Price (in dollars per share) $ 33.66    
Expected to Vest, Weighted Average Remaining Contractual Life (in years) 5 years 1 month 4 days    
Outstanding on December 31, 2016, Weighted-Average Remaining Contractual Life (in years) 5 years 1 month 10 days    
Outstanding on December 31, 2016, Aggregate Intrinsic Value (in dollars) $ 1,731.0    
Expected to vest, Aggregate Intrinsic Value (in dollars) $ 1,730.0    
Exercisable on December 31, 2016 166,000,000    
Exercisable on December 31, 2016 weighted average exercise price (in dollars per share) $ 31.96    
Exercisable on December 31, 2016, Weighted-Average Remaining Contractual Life (in years) 4 years 4 months 10 days    
Exercisable on December 31, 2016, Aggregate Intrinsic Value (in dollars) $ 1,580.0    
Total intrinsic value of options exercised $ 787.0 $ 594.0 $ 894.0
Number of Shares Available for Grant (in shares) 2,700,000    
Percent of Total Awards per Performance period 70.00%    
Percentage of awards not considered granted and no performance measure available in the reporting period 30.00%    
Vesting period of stock-based awards (in years) 4 years    
Summary disclosures      
Outstanding performance share units at the Threshold Award Level (in shares) 3,100,000    
Outstanding performance share units at the Maximum Award Level (in shares) 18,300,000    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other-than-Options Paid in Cash Equivalent in Period Value $ 1.9   $ 0.2
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 years    
CCE's North American business      
Share-based compensation disclosure      
Outstanding on December 31 700,000    
Outstanding on December 31, Weighted-Average Exercise Price (in dollars per share) $ 15.50    
Expiration period of stock-based awards (in years) 10    
Vesting period of stock-based awards (in years) 3 years    
2014 Equity Plan      
Share-based compensation disclosure      
Common stock was approved to be issued or transferred through the grant of stock options (in shares) 500,000,000    
Number of Shares Available for Grant (in shares) 448,300,000    
Stock options granted from 1999 through July 2003      
Share-based compensation disclosure      
Expiration period of stock-based awards (in years) 15 years    
Stock options granted in December 2003 and thereafter      
Share-based compensation disclosure      
Expiration period of stock-based awards (in years) 10 years    
Performance share units      
Summary disclosures      
Granted 3,502,000    
Paid in cash equivalent (in shares) (52,545)   (5,403)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other Than Options, Paid in Cash Equivalent in Period, Weighted-average Grant Date Fair Value $ 36.84    
Canceled/forfeited (in shares) (5,872,000)    
Outstanding on December 9,773,000 12,196,000  
Outstanding on January 1, 20161 $ 33.30    
Grants in Period, Weighted Average Grant Date Fair Value 39.70 $ 37.99 $ 32.33
Canceled/forfeited, Weighted-Average Grant-Date Fair Value (in dollars per share) 32.96    
Outstanding on December 31 $ 35.77 $ 33.30  
Performance share units | Performance Period 2014 to 2016 [Member]      
Summary disclosures      
Performance share units outstanding based on the target award amounts (in shares) 4,830,000    
Performance share units | Performance Period 2015 to 2017 [Member]      
Summary disclosures      
Performance share units outstanding based on the target award amounts (in shares) 1,640,000    
Performance share units | Performance Period 2016 to 2018 [Member]      
Summary disclosures      
Performance share units outstanding based on the target award amounts (in shares) 3,303,000    
Time-Based Restricted Stock Unit Awards      
Summary disclosures      
Performance share units outstanding based on the target award amounts (in shares) 770,244    
Restricted stock award plan [Member]      
Share-based compensation disclosure      
Number of Shares Available for Grant (in shares) 200,000    
Summary disclosures      
Restricted shares units vested and released (in shares) (7,101) (130,017) (6,773,934)
Restricted shares vested and released under performance share unit awards, total intrinsic value $ 1.0 $ 5.0 $ 255.0